Laporan Laba Rugi (TTM)
Laporan Laba Rugi Shanghai ZJ Bio-Tech Co., Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,479 | 2,052 | 2,491 | 2,140 | 2,114 | 2,019 | 2,173 | 2,591 | 2,421 | 2,326 | 1,601 | 994 | 649 | 274 | 241 | 222 | 207 | 179 | 160 |
Change (%) | 38.78 | 21.37 | -14.06 | -1.22 | -4.52 | 7.62 | 19.27 | -6.56 | -3.92 | -31.19 | -37.91 | -34.73 | -57.71 | -12.07 | -7.96 | -6.89 | -13.57 | -10.69 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 346 | 536 | 673 | 646 | 699 | 762 | 972 | 1,223 | 1,199 | 1,131 | 775 | 461 | 278 | 282 | 258 | 254 | 243 | 216 | 215 |
Change (%) | 55.00 | 25.70 | -3.99 | 8.10 | 9.11 | 27.45 | 25.90 | -1.97 | -5.72 | -31.46 | -40.47 | -39.64 | 1.32 | -8.52 | -1.46 | -4.47 | -11.06 | -0.47 | |
% of Revenue | 23.37 | 26.10 | 27.03 | 30.20 | 33.05 | 37.76 | 44.73 | 47.21 | 49.53 | 48.60 | 48.41 | 46.42 | 42.93 | 102.84 | 107.00 | 114.55 | 117.53 | 120.95 | 134.79 |
Gross Operating Profit | 1,133 | 1,517 | 1,817 | 1,494 | 1,416 | 1,256 | 1,201 | 1,368 | 1,222 | 1,196 | 826 | 532 | 370 | -8 | -17 | -32 | -36 | -37 | -56 |
Change (%) | 33.83 | 19.84 | -17.79 | -5.25 | -11.25 | -4.42 | 13.91 | -10.67 | -2.15 | -30.94 | -35.51 | -30.47 | -102.11 | 116.39 | 91.41 | 12.14 | 3.28 | 48.33 | |
% of Revenue | 76.63 | 73.90 | 72.97 | 69.80 | 66.95 | 62.24 | 55.27 | 52.79 | 50.47 | 51.40 | 51.59 | 53.58 | 57.07 | -2.84 | -7.00 | -14.55 | -17.53 | -20.95 | -34.79 |
SG&A | 265 | 328 | 367 | 343 | 349 | 267 | 286 | 333 | 286 | 348 | 280 | 223 | 209 | 186 | 181 | 179 | 172 | 160 | 156 |
Change (%) | 23.64 | 11.95 | -6.67 | 1.75 | -23.28 | 6.86 | 16.52 | -14.03 | 21.62 | -19.67 | -20.19 | -6.26 | -11.06 | -2.67 | -1.08 | -3.73 | -7.49 | -2.16 | |
% of Revenue | 17.93 | 15.98 | 14.74 | 16.00 | 16.48 | 13.24 | 13.15 | 12.85 | 11.82 | 14.96 | 17.47 | 22.46 | 32.25 | 67.83 | 75.08 | 80.70 | 83.44 | 89.32 | 97.85 |
R&D | 33 | 52 | 61 | 69 | 86 | 109 | 104 | 108 | 105 | 105 | 108 | 101 | 92 | 61 | 59 | 57 | 58 | 59 | 60 |
Change (%) | 61.11 | 16.54 | 12.62 | 24.54 | 26.95 | -4.09 | 3.56 | -2.85 | -0.33 | 3.23 | -6.62 | -8.64 | -33.79 | -3.87 | -2.57 | 1.03 | 1.83 | 2.43 | |
% of Revenue | 2.20 | 2.55 | 2.45 | 3.21 | 4.05 | 5.39 | 4.80 | 4.17 | 4.34 | 4.50 | 6.75 | 10.15 | 14.20 | 22.24 | 24.31 | 25.74 | 27.93 | 32.90 | 37.74 |
OpEx | 652 | 922 | 1,112 | 1,067 | 1,123 | 1,149 | 1,369 | 1,673 | 1,611 | 1,592 | 1,169 | 778 | 579 | 535 | 505 | 512 | 489 | 438 | 435 |
Change (%) | 41.39 | 20.61 | -3.98 | 5.20 | 2.34 | 19.16 | 22.21 | -3.71 | -1.16 | -26.58 | -33.49 | -25.57 | -7.49 | -5.63 | 1.35 | -4.59 | -10.34 | -0.69 | |
% of Revenue | 44.08 | 44.91 | 44.63 | 49.86 | 53.10 | 56.92 | 63.02 | 64.57 | 66.55 | 68.46 | 73.05 | 78.24 | 89.23 | 195.17 | 209.47 | 230.67 | 236.37 | 245.20 | 272.66 |
Operating Income | 827 | 1,131 | 1,379 | 1,073 | 992 | 870 | 803 | 918 | 810 | 734 | 431 | 216 | 70 | -261 | -264 | -290 | -282 | -259 | -275 |
Change (%) | 36.72 | 21.98 | -22.18 | -7.59 | -12.29 | -7.64 | 14.27 | -11.76 | -9.41 | -41.21 | -49.88 | -67.68 | -473.64 | 1.15 | 9.86 | -2.83 | -7.97 | 6.20 | |
% of Revenue | 55.92 | 55.09 | 55.37 | 50.14 | 46.90 | 43.08 | 36.98 | 35.43 | 33.45 | 31.54 | 26.95 | 21.76 | 10.77 | -95.17 | -109.47 | -130.67 | -136.37 | -145.20 | -172.66 |
Interest Expense | -0 | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -1 | |||||||||
Change (%) | 15.22 | 19.78 | 11.76 | -50.84 | 0.04 | -3.02 | -4.23 | 5.41 | 102.12 | ||||||||||
% of Revenue | -0.02 | -0.03 | -0.06 | -0.11 | -0.13 | -0.15 | -0.15 | -0.16 | -0.19 | -0.44 | |||||||||
Net Income | 696 | 932 | 1,150 | 891 | 839 | 759 | 718 | 850 | 784 | 760 | 491 | 314 | 167 | -137 | -116 | -142 | -185 | -127 | -170 |
Change (%) | 33.93 | 23.38 | -22.51 | -5.81 | -9.62 | -5.38 | 18.38 | -7.71 | -3.04 | -35.44 | -36.03 | -46.95 | -182.16 | -15.26 | 22.85 | 29.51 | -30.92 | 33.68 | |
% of Revenue | 47.06 | 45.42 | 46.17 | 41.63 | 39.69 | 37.57 | 33.04 | 32.79 | 32.39 | 32.68 | 30.67 | 31.60 | 25.68 | -49.89 | -48.08 | -64.17 | -89.26 | -71.35 | -106.79 |
Source: Capital IQ